From: DCYTB is a predictor of outcome in breast cancer that functions via iron-independent mechanisms
Name | Number | Eventd (%) | Median recurrence-free survival (years) | Median follow-up (years) | Mean age, years (SD) | ER +/- | LN +/- | Her2 | PR +/- | Grade 1/2/3 | Normal tissue | Reference |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Cohort #1a | 741 | 167 (22) | 7.8 | 8.7 | 60.8 (12.5) | 643/89 | 364/358 | NA | NA/NA | 153/314/188 | NA | Miller et al. [32] |
Cohort #2b | 869 | 251 (29) | 4.3 | 4.5 | 51(11.1) | 486/276 | 342/426 | 6 | 239/250 | 43/209/309 | 14c | Â |
GSE25055 | 303 | 63 (21) | 2.4 | 2.6 | 50 (10.3) | 170/133 | 217/86 | 4 | 140/157 | 19/113/149 | NA | Hatzis et al. [40] |
GSE25065 | 193 | 42 (22) | 3.2 | 3.7 | 49.2 (10.6) | 120/72 | 125/68 | 2 | 99/93 | 13/59/107 | NA | Hatzis et al. [40] |
GSE2034 | 272 | 100 (37) | 7.2 | 8.6 | 54 (12) | 196/76 | 0/272 | NA | NA/NA | NA | NA | Wang et al. [73] |
GSE42568 | 101 | 46 (46) | 5.3 | 6.2 | 58.6 (11.6) | 65/33 | 58/43 | NA | NA/NA | 11/37/53 | 14c | Clarke et al. [74] |